我们向大家呈现了使用Versius手术系统（由英国剑桥的CMR Surgical Ltd.公司制造）进行机器人辅助激光前列腺切除术（RARP）的第一组患者治疗结果。与传统的开放式前列腺切除术相比，RARP在围手术期结果上表现出更好的效果。然而，由于平台可用性和成本效益问题，RARP的应用仍然受到限制。新机器人手术平台的竞争不断增加，可能进一步推动机器人手术的使用。我们在过去的三个月内，对我们中心前列腺癌患者的连续前18例进行了机器人辅助前列腺切除术，并进行了前瞻性数据收集。我们记录了患者的人口统计学数据和围手术期结果。我们还报告了我们优化的设置，包括穿刺器的放置、患者床边单元的放置以及手术室整体组织，以便进行这种手术。我们描述了为实现设置和手术时间缩短而进行的渐进修改的情况，以优化Versius系统的应用。设置时间的中位数为8.5分钟（IQR 7-10）。控制台时间的中位数为201分钟（IQR 170-242）。手术时间的中位数为213分钟（IQR 186-266）。总手术时间的中位数为226分钟（IQR 201-277）。双侧盆腔淋巴结切除的中位数时间为19分钟（IQR 17-20）。未记录到与Versius手术系统的使用相关的并发症和/或限制，包括转化的需求。在Versius机器人系统的使用方面，在术后1个月的随访中，没有相关的术中或术后并发症。患者在中位数为4天（IQR 3.75-5）后出院，经尿道膀胱导管撤除后平均为8天（范围7-14）。术后2个月，72.2％患者完全恢复大小便控制。使用Versius手术系统进行RARP是可行、安全且易于复制的。我们的设置支持快速装卸和高效完成手术。本文受版权保护。版权所有。

We present the results of the first series of patients treated with Robot-assisted radical prostatectomy (RARP) with the use of Versius Surgical System (CMR Surgical Ltd., Cambridge, UK). RARP has demonstrated better peri-operative outcomes compared to open radical prostatectomy. However, RARP remains limited by platform availability and cost-effectiveness issues. The increasing competition from new robotic surgical platforms may further drive utilization of the robotic approach.Data was collected prospectively for our first eighteen consecutive patients with localized prostate cancer who underwent robot-assisted radical prostatectomy at our center over a 3-month period. We recorded parameters, including patient demographics and periperative outcomes. We also report our optimized setup with regard to trocar placement, bedside unit placement and overall composition of the operating room for this procedure. Describing the incremental modifications carried out to achieve reductions in set-up and operating times to optimize utilization of the Versius system.Median set-up time was 8.5 min (IQR 7-10). Median console time was 201 min (IQR 170-242). Median operative time was 213 min (IQR 186-266). Median total surgery time was 226 min (IQR 201-277). Bilateral pelvic lymphadenectomy median time was 19 min (IQR 17-20). No complications and/or limitations related to the use of Versius Surgical System including need for conversion were recorded. There were no relevant intra- or postoperative complications at 1-month follow-up related to the use of Versius Robotic System. Patients were discharged after median of 4 days (IQR 3.75-5), and transurethral catheter was withdrawn after a mean of 8 days (range 7-14). Continence at 2 months was achieved in 72.2% of the patients.Performing RARP using Versius Surgical System is feasible, safe and easy reproducible. Our setup enables rapid docking approach and efficient completion of the surgery.This article is protected by copyright. All rights reserved.